Clinical Trial Update: Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

View source ↗

Summary

This clinical trial update describes a real-world data collection study of lorlatinib in pediatric neuroblastoma. The study was terminated and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• lorlatinib (lorlatinib)

Snippet

Sponsor: Pfizer | Conditions: Neuroblastoma | Status: TERMINATED | Results posted: 2024-09-23